c-Cbl acts as a mediator of Src-induced activation of the PI3K-Akt signal transduction pathway during TRAIL treatment
- 31 March 2010
- journal article
- research article
- Published by Elsevier BV in Cellular Signalling
- Vol. 22 (3), 377-385
- https://doi.org/10.1016/j.cellsig.2009.10.007
Abstract
No abstract availableKeywords
Funding Information
- NCI (CA121395, CA140554, CA113263)
- Ministry of Education, Science and Technology (2009-0071809)
- Yonsei University College of Medicine (2009-0113)
- Ministry of Commerce, Industry, and Energy of Korea (990-14-05)
This publication has 35 references indexed in Scilit:
- The E3 Ligase TRAF6 Regulates Akt Ubiquitination and ActivationScience, 2009
- Differential cleavage of Mst1 by caspase-7/-3 is responsible for TRAIL-induced activation of the MAPK superfamilyCellular Signalling, 2008
- TRAIL promotes metastasis of human pancreatic ductal adenocarcinomaOncogene, 2006
- Overcoming Acquired Resistance to TRAIL by Chemotherapeutic Agents and Calpain Inhibitor I through Distinct MechanismsMolecular Therapy, 2004
- Inhibition of Src Family Kinases Blocks Epidermal Growth Factor (EGF)-induced Activation of Akt, Phosphorylation of c-Cbl, and Ubiquitination of the EGF ReceptorPublished by Elsevier BV ,2002
- On the TRAIL to apoptosisCytokine & Growth Factor Reviews, 2002
- Protein Kinase B Regulates T Lymphocyte Survival, Nuclear Factor κb Activation, and Bcl-XL Levels in VivoThe Journal of Experimental Medicine, 2000
- Induction of NF-κB by the Akt/PKB kinaseCurrent Biology, 1999
- Induction of Apoptosis by Apo-2 Ligand, a New Member of the Tumor Necrosis Factor Cytokine FamilyJournal of Biological Chemistry, 1996
- Phosphatidylinositol 3’ kinase: one of the effectors of RasPhilosophical Transactions Of The Royal Society B-Biological Sciences, 1996